Article
Race, APOL1 Risk, and eGFR Decline in the General Population.
Journal of the American Society of Nephrology : JASN - 1 Sept 2016
Grams Morgan E, Rebholz Casey M, Chen Yuan, Rawlings Andreea M, Estrella Michelle M, Selvin Elizabeth, Appel Lawrence J, Tin Adrienne, Coresh Josef
Abstract excerpt
The APOL1 high-risk genotype, present in approximately 13% of blacks in the United States, is a risk factor for kidney function decline in populations with CKD. It is unknown whether genetic screening is indicated in the general population. We evaluated the prognosis of APOL1 high-risk status in participants in the population-based Atherosclerosis Risk in Communities (ARIC) study, including associations with eGFR...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
